Some compounds known to inhibit CYP3A may possibly maximize publicity to zolpidem. The result of inhibitors of other P450 enzymes around the pharmacokinetics of zolpidem is unfamiliar.Zolpidem is a GABA A receptor positive modulator presumed to exert its therapeutic outcomes inside t